Durapindol
Durapindol Brand names, Durapindol Analogs
Durapindol Brand Names Mixture
- Viskazide 10/25tab (Hydrochlorothiazide + Pindolol)
- Viskazide 10/50tab (Hydrochlorothiazide + Pindolol)
Durapindol Chemical_Formula
C14H20N2O2
Durapindol RX_link
http://www.rxlist.com/cgi/generic3/pindolol.htm
Durapindol fda sheet
Durapindol msds (material safety sheet)
Durapindol Synthesis Reference
No information avaliable
Durapindol Molecular Weight
248.321 g/mol
Durapindol Melting Point
167-171 oC
Durapindol H2O Solubility
7880 mg/L
Durapindol State
Solid
Durapindol LogP
2.525
Durapindol Dosage Forms
Tablet
Durapindol Indication
For the management of hypertension, edema, ventricular tachycardias, and atrial fibrillation.
Durapindol Pharmacology
Pindolol is a non-selective beta-adrenergic antagonist (beta-blocker) which possesses intrinsic sympathomimetic activity (ISA) in therapeutic dosage ranges but does not possess quinidine-like membrane stabilizing activity. Pindolol impairs AV node conduction and decreases sinus rate and may also increase plasma triglycerides and decrease HDL-cholesterol levels. Pindolol is nonpolar and hydrophobic, with low to moderate lipid solubility. Pindolol has little to no intrinsic sympathomimetic activity and, unlike some other beta-adrenergic blocking agents, pindolol has little direct myocardial depressant activity and does not have an anesthetic-like membrane-stabilizing action.
Durapindol Absorption
Rapidly and reproducibly absorbed (bioavailability greater than 95%).
Durapindol side effects and Toxicity
LD50=263 mg/kg (orally in rats). Signs of overdose include excessive bradycardia, cardiac failure, hypotension, and bronchospasm.
Durapindol Patient Information
Durapindol Organisms Affected
Humans and other mammals
